| Code | 6267D | ||||||||||
| MA number | EU/1/20/1492/001 | ||||||||||
| Product Form: | dis inf 1x68 ml (vak EVA) | ||||||||||
| MA Status: | Ex - Conditional centralised marketing authorisation | ||||||||||
| Type of procedure: | EU Orphan | ||||||||||
| MAH, country: | Kite Pharma EU B.V, Netherland | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 12 | ||||||||||
| Container: | bag ethylene vinyl acetate (EVA) | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 14.12.2020 |
| Validity: | 15.12.2025 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Pokyny pre zaobchádzanie s liekom SK.pdf
|
| Dokument: |
DHPC_CAR-T cells_18.07.2024.pdf
|
| Dokument: |
Yescarta_Tecartus_Príručka pre zdravotníckych pracovníkov.pdf
|
| Dokument: |
Yescarta_Tecartus_Karta pacienta.pdf
|
| Safety feature | No |
| Data update: | 04.03.2025 |
